Verve Therapeutics Company
Verve is focused on discovering and developing therapies that safely edit the genomes of adults to confer protection against coronary.
Technology:
Small Molecules
Industry:
Gene therapy
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2018
Employees Number:
101-250
Funding Status:
IPO
Total Funding:
215500000
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series B
Register and Claim Ownership